ArticleDigital health
Delivering HPV results via telehealth: Patient needs and engagement following an at-home self-collection study.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations.Cancer control : journal of the Moffitt Cancer CenterTrial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study evaluated the complete patient experience of at-home self-collection for cervical cancer screening using the Teal Wand, the United States Food and Drug Administration (FDA)-authorized vaginal self-collection device, paired with a Health Insurance Portability and Accountability Act (HIPAA)-secure telehealth platform. Introduction: The data assesses patients' understanding, experiences, and engagement, particularly around results delivery. The findings inform telehealth strategies that can improve patients' human papillomavirus (HPV) results experience, build HPV awareness, facilitate follow-up care when needed, and increase screening adherence. Methods: A prospective, mixed-methods cohort usability study was conducted using structured surveys and in-depth interviews, supplemental to prospective clinical validation. Thirty participants used the Teal Wand and completed surveys after major touchpoints. A subset ( Results: All participants (30/30) completed self-collection, with 4.7/5 average satisfaction score. Most (93%) found the platform easily navigable and results easy to access and understand. All participants viewed results within 1.5 hours on average and understood next steps. Among those needing follow-up ( Conclusions: At-home cervical cancer screening supported by a tailored telehealth platform is usable and acceptable. Thoughtful results delivery can improve patient comprehension, reduce anxiety, and strengthen future adherence, supporting broader efforts to increase screening access and reduce cervical cancer burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.